2′-O-Methylperlatolic Acid Enhances Insulin-Regulated Blood Glucose-Lowering Effect through Insulin Receptor Signaling Pathway
Purpose. Insulin receptor (InsR) sensitizers represent a new type of therapeutic agent for the treatment of diabetes, with 2′-O-methylperlatolic acid (2-O-M) being a potential InsR targeting drug. The purpose of this study was to determine whether 2-O-M functions as an activator of the insulin signa...
Saved in:
Main Authors: | Wang Yinghao, Guan Qiaoli, Liu Guanfu, Wu Xiaoyun, Wang Xuanjun, Sheng Jun |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Journal of Diabetes Research |
Online Access: | http://dx.doi.org/10.1155/2022/2042273 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Inositols in Insulin Signaling and Glucose Metabolism
by: Arturo Bevilacqua, et al.
Published: (2018-01-01) -
The Insulin Signaling Pathway and Aging in Drosophila
by: Linda Partridge
Published: (2001-01-01) -
Blood Glucose Control Using a Novel Continuous Blood Glucose Monitor and Repetitive Intravenous Insulin Boluses: Exploiting Natural Insulin Pulsatility as a Principle for a Future Artificial Pancreas
by: Nils K. Skjaervold, et al.
Published: (2013-01-01) -
Assessment of Insulin Resistance in Subjects with Normal Glucose Tolerance, Hyperinsulinemia with Normal Blood Glucose Tolerance, Impaired Glucose Tolerance, and Newly Diagnosed Type 2 Diabetes (Prediabetes Insulin Resistance Research)
by: Guang Yang, et al.
Published: (2016-01-01) -
Inhibition of MEK1 Signaling Pathway in the Liver Ameliorates Insulin Resistance
by: Atsunori Ueyama, et al.
Published: (2016-01-01)